Who We Are
The goal of the John Ring LaMontagne Center for Infectious Disease is to bridge the gap between basic and translational research into bacterial and viral pathogens. Emerging infections, including the current coronavirus epidemic and multi-drug resistant bacteria, pose an enormous health risk, and current treatment options are limited. Research is needed to better understand the biology of these organisms, the host immune response to the infections, and new therapies to prevent or treat the infections.
What We’re Fundraising For
We will provide seed grants for LaMontagne Center investigators to initiate ground-breaking research projects on new and emerging diseases, immunotherapies, and vaccines. Your donation will play a role in the development of new treatments, infectious disease prevention and future infection predictions. These funds will support the LCIDs efforts to revolutionize health practices for many deadly diseases.
Graduate students and postdoctoral fellows are at the heart of our research programs and are the next generation of infectious disease researchers. Your donations will provide supplements to attract and retain the best and brightest to UT.
Research by LCID members is having a profound impact on the prevention and treatment of infectious diseases. Their work has led to treatments for anthrax and other infections, development of gene therapy vectors, novel peptide antibiotics, and vaccines, among other discoveries.